• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Huawei, WuXi AppTec partner on China Precision Medicine Cloud Platform

Huawei, WuXi AppTec partner on China Precision Medicine Cloud Platform

March 17, 2016
CenterWatch Staff

Huawei, a global information and communications technology provider, and WuXi AppTec, a global open-access R&D platform, have announced the signing of a strategic framework agreement to support the China Precision Medicine Initiative (China PMI) through the creation of a state-of the-art precision medicine cloud platform. The agreement builds on Huawei's capabilities and reach in cloud infrastructure, and the genomics and precision medicine expertise of WuXi NextCODE, the global genomic information and precision medicine subsidiary of WuXi AppTec.

Cloud computing is the way genomic big data will be used to drive precision medicine innovation and deliver better healthcare in a cost-efficient manner. WuXi AppTec and Huawei will follow the guidance of the China Food and Drug Administration (CFDA) and work closely with third-party secure life-science cloud providers to develop the data standards and exchange framework required to deliver the China PMI.

"We are excited and honored to be working with Huawei as our key public cloud technology partner to support the China PMI," said Dr. Ge Li, chairman and CEO of WuXi AppTec. "This partnership aims to deliver the benefits of genomic medicine to patients on an unprecedented scale, and together we have the world-leading technology to achieve that ambition."

"This partnership is a win-win-win—for our companies and for the patients that will benefit from the vision of the China PMI," said Hannes Smarason, COO of WuXi NextCODE. "Our technology underpins genome-driven medicine at Genomics England, the Qatar Genome Project, Boston Children's Hospital and Harvard Medical School, and in China at Fudan University. We are thrilled to be deploying it with Huawei across China, a key part of our strategy to advance a global standard for turning the genome into better health."

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing